Tesla’s been slammed by investors lately, and while the stock is down nearly 20% this year, I’m diving deep into whether it’s finally trading below intrinsic value. I break down the numbers, separate hype from reality, and show how Tesla’s fundamentals stack up today—amid flattening growth, falling
1 extracted signal · 1 resolved · 0 still active
Everything MoneyIndependent analyst profile- Source published
- 07 Aug 2025, 09:54 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analyst believes that TSLA is overvalued, offering a long-term (10Y) analysis. The video mentions several important numbers and analyst estimates. The presenter believes that the analysts may be wrong, showing his projected earnings per share growth moving from 2 dollars up to 9.73 dollars over the next four to five years. Also, this will cause revenues to grow from $100B to $250B. The P/S ratio for TSLA is 11.75. The long run estimated value for the stock is the target 106, low price of 35 dollars and a high price of 272. He presents his price / value conclusion with charts comparing the high / lows and moving averages.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Everything Money
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
